MRK - Sell-siders weight in on ESMO data presentations September, 27 2019 08:13 AM Merck & Company Inc. Sell-side analysts comment on cancer therapy data to be presented at ESMO in Barcelona starting today.More news on: Seattle Genetics, Inc., Clovis Oncology, Inc., AstraZeneca PLC, Healthcare stocks news, Read more ...